CFO van Houte Hans sold 20,000 NRIX shares at $25.22, reducing holdings by 39.2%, as stock rebounds 65.3% in 90 days.
CFO van Houte Hans sold 20,000 shares (39.2% of pre-transaction holdings) at $25.22 on 2024-08-26, leaving him with 31,002 shares. The transaction occurs against a backdrop of significant positive price momentum: the stock has risen 65.3% over the past 90 days and currently trades at $25.69, near its 52-week high of $25.69. However, the company's fundamentals present a mixed picture. While revenue growth of 99.3% year-over-year demonstrates strong business expansion with quarterly revenue of $12.1M, Nurix remains unprofitable with a net loss of $44.5M over its most recent full fiscal year. The sale represents a material reduction in executive stake during a period of stock appreciation, though it occurred at a price point near current market levels rather than at depressed valuations.